MedPath

IMUFLEX WB-SP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) and OPTISOL (AS-5) Red Cell Preservative

IMUFLEX WB-SP BLOOD BAG SYSTEM with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm CPD/OPTISOL SOLUTION

Approved
Approval ID

0d72d5a6-1676-452d-af8b-7a977a9fc103

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 13, 2018

Manufacturers
FDA

Terumo Corporation

DUNS: 690543319

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Anticoagulant Citrate Phosphate Dextrose (CPD) and AS-5 Red Cell Preservative

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53877-007
Application NumberBN880217
Product Classification
M
Marketing Category
C73594
G
Generic Name
Anticoagulant Citrate Phosphate Dextrose (CPD) and AS-5 Red Cell Preservative
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 13, 2018
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IMUFLEX WB-SP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) and OPTISOL (AS-5) Red Cell Preservative - FDA Drug Approval Details